Navigation Links
Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study
Date:9/3/2008

of the open-label, large sample, multi-center Endu phase IV clinical study affirms the safety and therapeutic efficacy of Endu acting in conjunction with platinum-based chemotherapy. With our continued research of Endu Phase IV, we will collect more clinical data to further evaluate the safety and efficacy of Endu."

To date, over 2,000 NSCLC patients have been recruited for Endu Phase IV clinical study. The final results of the study will be announced in the first half of 2010.

As a leading patented anti-cancer biotech product in China, Endu is recommended in the National Comprehensive Cancer Network of China Clinical Practice Guidelines in Oncology Chinese Version (2006-2008)as a first line treatment for NSCLC.

About Simcere Pharmaceutical Group

Simcere Pharmaceutical Group (NYSE: SCR, Simcere) is a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu in the rapidly growing China market. In recent years, Simcere has been focusing its strategy on the development of first-to-market generic and innovative pharmaceuticals, and has introduced a first-to-market generic stroke management medication under the brand name Bicun and an innovative anti-cancer medication under the brand name Endu. Simcere currently manufactures and sells more than 50 pharmaceutical products including antibiotics, anti-cancer medication and stroke management medication and is the exclusive distributor of three additional pharmaceuticals that are marketed under its brand names. Simcere concentrates its research and development efforts on the treatment of diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmac
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD)
2. Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies
3. Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
4. Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000
5. Catalyst Pharmaceutical Partners Announces Publication of Animal Data Demonstrating Vigabatrin Effective for Weight Loss
6. Addrenex Pharmaceuticals New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation
7. Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy
8. Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome)
9. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
10. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
11. Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has announced the ... Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) ... in order to treat dental impairments, for tooth restoration ...
(Date:1/15/2014)... AARP Foundation today announced it has established a ... severe cold weather that has gripped much of the nation. ... need; so to support these emergency relief efforts AARP and ... could mean up to $500,000 in aid. The matching program ...
(Date:1/15/2014)...  Celsion Corporation (the "Company") (NASDAQ: CLSN ) ... investors to purchase an aggregate of approximately $15 million ... direct offering, led by a dedicated health care fund. ... with these investors pursuant to which the Company agreed ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3
(Date:7/9/2014)... Vasectomy was associated with a small increased risk of ... lethal prostate cancer according to a new study from ... that the association remained even among men who received ... cancer cannot be explained by diagnostic bias. It is ... look at the link between vasectomy and prostate cancer. ...
(Date:7/9/2014)... of signals active in almost all types of cancer ... and may help fuel a tumour,s uncontrolled growth, new ... Research, London, identified a molecular trigger responsible for ratcheting ... cellular factory that makes the building blocks cancer cells ... TOR signalling pathway, called SREBP, controls the flow of ...
(Date:7/9/2014)... research into the metabolism of stromal support cells and ... of these cell types in the development of diseases ... conditions and cancer. That was the conclusion of a ... in the leading journal Nature . , Prof. ... wake-up call. The metabolism of cancer cells has been ...
(Date:7/9/2014)... drug users in Russia might contribute to HIV ... conducted by researchers from Boston University Schools of ... Petersburg Pavlov State University, sought to discover the ... of a cohort of HIV-positive people with lifetime ... arrested by police were more likely to share ...
(Date:7/9/2014)... news release is available in French . ... factors in 14 year old teens, including brain structure and ... 70% accuracy who will go on to develop binge drinking ... of conscientiousness, and other variables such as life events and ... of binge drinking. Whether or not the child had ...
Breaking Medicine News(10 mins):Health News:Vasectomy may increase risk of aggressive prostate cancer 2Health News:Signal may send cancer's cellular factories into overdrive 2Health News:Wake-up call for more research into cell metabolism 2Health News:BU researchers relate arrests with HIV risk environment 2Health News:What drives a child to abuse alcohol? 2
... Academy of Ophthalmology and the Texas Ophthalmological, Association Remind Parents and ... Eyewear for Youth Sports and Back-to-School ... when an errant paintball smashed into his left eye and sent ... "I remember being very dizzy and I couldn,t stop vomiting," ...
... WASHINGTON, Sept. 1 /PRNewswire-USNewswire/-- Service Employees,International Union (SEIU) ... RN, issued the following statement regarding the work,being ... country in anticipation of,the health impacts of Hurricane ... the Gulf Coast, leaders of the Nurse,Alliance of ...
... Israel, Aug. 31 Elbit Imaging Ltd.,(Nasdaq: EMITF ... for the,second quarter of 2008., Profit for the ... US$ 16.7 million) of which profit of NIS 15.8 ... holders of,the Company and NIS 40.3 million (approximately US$ ...
... WASHINGTON, Aug. 31 As mandatory evacuations are ... is starting to receive,evacuees in shelters throughout the Gulf ... states: Alabama, Mississippi, Louisiana and Texas.,Everyone in the path ... officials,and heed evacuation orders when instructed to do so; ...
... Spanish . , The brain is the ... a complex, orchestrated manner that is related to the activation ... cognitive and emotional processes. It is the brain which finally ... stressful for us, and which regulates the stress responses that ...
... HAMILTON August 31, 2008 -- An international study ... medication used to lower blood pressure, reduced the outcome ... who are unable to tolerate a widely available and ... Teo, professors in the Michael G. DeGroote School of ...
Cached Medicine News:Health News:Keep Eyes Safely On The Ball 2Health News:Keep Eyes Safely On The Ball 3Health News:Nurse Alliance of SEIU Healthcare Mobilizing RNs and Medical Supplies to Gulf Coast Areas in Advance of Hurricane Gustav 2Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 2Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 3Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 4Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 5Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 6Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 7Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 8Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 9Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 10Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 11Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 12Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 13Health News:Elbit Imaging Ltd. Announces Second Quarter Results for 2008 14Health News:American Red Cross Relief Efforts Underway for Gustav 2Health News:Neurogenesis in the adult brain: The association with stress and depression 2Health News:Neurogenesis in the adult brain: The association with stress and depression 3Health News:Neurogenesis in the adult brain: The association with stress and depression 4Health News:Neurogenesis in the adult brain: The association with stress and depression 5Health News:Global study shows telmisartan reduces outcome of cardiovascular death, heart attack or stroke 2
BD Vacutainer Citrate Tubes with 3.2% buffered sodium citrate solution are used for routine coagulation studies....
... Cross-match tubes are available ... serum tube contains a clotting ... cross-match tests where serum is ... EDTA cross-match tube is suitable ...
... tubes are available in two ... contains a clotting activator and ... where serum is required for ... tube is suitable where the ...
Inquire...
Medicine Products: